Literature DB >> 27350673

Genetic polymorphisms of T-1131C APOA5 and ALOX5AP SG13S114 with the susceptibility of ischaemic stroke in Morocco.

Brehima Diakite1, Khalil Hamzi, Wiam Hmimech, Sellama Nadifi.   

Abstract

Ischaemic stroke is a multifactorial disease. Genetic polymorphisms involved in lipid, inflammatory and thrombotic metabolisms play an important role in the development of ischaemic stroke. The present study aimed to assess the relationship between T1131C APOA5 and SG13S114 ALOX5AP polymorphisms and the risk of ischemic stroke in 175 cases and 201 controls. Genotyping was performed by high resolution melting and polymerase chain reaction restriction fragment length polymorphism methods. In the case of T-1131C APOA5, a modest risk of ischaemic stroke was noticed with CC (OR: 2.86; 95% CI = 1.24-6.58; Pc = 0.039) and C allele (OR: 1.54; 95% CI = 1.01-2.33; Pc = 0.014). For SG13S114 ALOX5AP, a significant association was observed among subjects with TT (OR: 2.57; 95% CI =1.49-4.83; Pc = 0.009) and T allele (OR: 1.59; 95% CI = 1.16-2.19; Pc = 0.008). According to the risk factors of ischaemic stroke, a positive correlation was observed only between SG13S114 variant of ALOX5AP gene and hypertension (Pc = 0.026). Despite lower sample size, T-1131C APOA5 and SG13S114 variants could be considered an independent genetic risk factor of ischaemic stroke in Moroccan population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27350673     DOI: 10.1007/s12041-016-0635-0

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  38 in total

Review 1.  The global stroke initiative.

Authors:  Ruth Bonita; Shanthi Mendis; Thomas Truelsen; Julien Bogousslavsky; James Toole; Frank Yatsu
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

Review 2.  High-resolution DNA melting analysis for simple and efficient molecular diagnostics.

Authors:  Gudrun H Reed; Jana O Kent; Carl T Wittwer
Journal:  Pharmacogenomics       Date:  2007-06       Impact factor: 2.533

Review 3.  Leukotrienes and atherosclerosis.

Authors:  Graziano Riccioni; Magnus Bäck; Valérie Capra
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

4.  Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke.

Authors:  James F Meschia; Thomas G Brott; Robert D Brown; Richard Crook; Bradford B Worrall; Brett Kissela; W Mark Brown; Stephen S Rich; L Douglas Case; E Whitney Evans; Stephen Hague; Andrew Singleton; John Hardy
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

5.  Association of ALOX5AP1 SG13S114T/A variant with ischemic stroke, stroke subtypes and aspirin resistance.

Authors:  Vandana Sharma; Sneha Dadheech; Subhash Kaul; A Jyothy; Anjana Munshi
Journal:  J Neurol Sci       Date:  2013-06-06       Impact factor: 3.181

Review 6.  Genetics and ischaemic stroke.

Authors:  A Hassan; H S Markus
Journal:  Brain       Date:  2000-09       Impact factor: 13.501

7.  Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke.

Authors:  Luca Járomi; Veronika Csöngei; Noémi Polgár; Zoltán Szolnoki; Anita Maász; Katalin Horvatovich; Bernadett Faragó; Csilla Sipeky; Eniko Sáfrány; Lili Magyari; Péter Kisfali; Márton Mohás; Ingrid Janicsek; Lilla Lakner; Béla Melegh
Journal:  J Mol Neurosci       Date:  2009-10-22       Impact factor: 3.444

8.  Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

Authors:  Csaba Szalai; Márton Keszei; Jenõ Duba; Zoltán Prohászka; Gergely Tibor Kozma; Albert Császár; Sándor Balogh; Zsuzsa Almássy; George Fust; Antal Czinner
Journal:  Atherosclerosis       Date:  2004-03       Impact factor: 5.162

9.  PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.

Authors:  Konstantinos Kostulas; Solveig Gretarsdottir; Vasilios Kostulas; Andrei Manolescu; Anna Helgadottir; Gudmar Thorleifsson; Larus J Gudmundsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Kari Stefansson; Jan Hillert
Journal:  J Neurol Sci       Date:  2007-07-25       Impact factor: 3.181

10.  Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients.

Authors:  Sanaa Ouatou; Maria Ajjemami; Hicham Charoute; Hajar Sefri; Noreddine Ghalim; Houria Rhaissi; Houda Benrahma; Abdelhamid Barakat; Hassan Rouba
Journal:  Lipids Health Dis       Date:  2014-04-01       Impact factor: 3.876

View more
  6 in total

1.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

2.  The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang.

Authors:  Yun-Hua Yue; Ling-Yun Liu; Liang Hu; You-Mei Li; Jie-Ping Mao; Xiao-Ying Yang; Na-Mu Dila
Journal:  Lipids Health Dis       Date:  2017-06-17       Impact factor: 3.876

3.  Lack of association between ALOX5AP genetic polymorphisms and risk of ischemic stroke: evidence from meta-analyses.

Authors:  Jing-Hui Zheng; Gui-Lan Ning; Wen-Hua Xu; Xin-Cheng Wu; Xiao-Cong Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-25       Impact factor: 2.570

4.  Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients.

Authors:  Jerry Jacob; Sylwia Boczkowska; Wojciech Zaluska; Monika Buraczynska
Journal:  BMC Nephrol       Date:  2022-09-07       Impact factor: 2.585

5.  Ischemic stroke in Morocco: a systematic review.

Authors:  Ahmed Kharbach; Majdouline Obtel; Laila Lahlou; Jehanne Aasfara; Nour Mekaoui; Rachid Razine
Journal:  BMC Neurol       Date:  2019-12-30       Impact factor: 2.474

Review 6.  Stroke in Africa: profile, progress, prospects and priorities.

Authors:  Rajesh N Kalaria; Mayowa O Owolabi; Rufus O Akinyemi; Bruce Ovbiagele; Olaleye A Adeniji; Fred S Sarfo; Foad Abd-Allah; Thierry Adoukonou; Okechukwu S Ogah; Pamela Naidoo; Albertino Damasceno; Richard W Walker; Adesola Ogunniyi
Journal:  Nat Rev Neurol       Date:  2021-09-15       Impact factor: 42.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.